This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2021
  • /
  • 3
  • /
  • Health Canada approves COVID 19 AstraZeneca vaccin...

Health Canada approves COVID 19 AstraZeneca vaccine to prevent COVID-19.

Read time: 1 mins
Published:16th Mar 2021
Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19) and a related shot by the Serum Institute of India for use in Canada .A version of the AstraZeneca vaccine by the Indian pharmaceutical company Serum Institute of India and sponsored by Verity Pharmaceuticals Inc. in Canada has also been approved for use and is considered a separate vaccine by Health Canada. AstraZeneca’s vaccine is made from a chimpanzee adenovirus that’s been genetically modified to carry the spike protein of SARS-CoV-2, the virus that causes COVID-19. When injected, the shot,also called AZD1222, triggers an immune response, producing antibodies and memory cells. These allow the body to remember the spike protein and respond effectively in defence against the coronavirus.Health Canada is recommending AZD1222 be given in two doses, between four and 12 weeks apart.
Condition: Coronavirus/COVID-19 Infection
Type: drug

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.